A detailed history of Stewart Asset Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Stewart Asset Management, LLC holds 46,297 shares of ABT stock, worth $5.43 Million. This represents 3.9% of its overall portfolio holdings.

Number of Shares
46,297
Previous 49,681 6.81%
Holding current value
$5.43 Million
Previous $4.81 Million 5.74%
% of portfolio
3.9%
Previous 3.49%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023

SELL
$95.06 - $111.52 $321,683 - $377,383
-3,384 Reduced 6.81%
46,297 $5.08 Million
Q3 2022

Nov 08, 2022

BUY
$96.76 - $112.03 $638,906 - $739,734
6,603 Added 15.33%
49,681 $4.81 Million
Q2 2022

Aug 03, 2022

SELL
$102.07 - $123.37 $774,098 - $935,638
-7,584 Reduced 14.97%
43,078 $4.68 Million
Q1 2022

May 11, 2022

BUY
$114.02 - $139.04 $873,165 - $1.06 Million
7,658 Added 17.81%
50,662 $6 Million
Q4 2021

Feb 14, 2022

SELL
$115.53 - $141.46 $746,901 - $914,538
-6,465 Reduced 13.07%
43,004 $6.05 Million
Q3 2021

Nov 15, 2021

SELL
$116.66 - $129.06 $380,194 - $420,606
-3,259 Reduced 6.18%
49,469 $5.84 Million
Q2 2021

Aug 11, 2021

BUY
$105.79 - $124.53 $1.65 Million - $1.94 Million
15,613 Added 42.07%
52,728 $6.11 Million
Q1 2021

May 14, 2021

SELL
$108.84 - $128.23 $83,371 - $98,224
-766 Reduced 2.02%
37,115 $4.45 Million
Q4 2020

Feb 12, 2021

BUY
$105.0 - $114.42 $743,610 - $810,322
7,082 Added 22.99%
37,881 $4.15 Million
Q3 2020

Nov 16, 2020

SELL
$91.64 - $111.29 $57,458 - $69,778
-627 Reduced 2.0%
30,799 $3.35 Million
Q2 2020

Aug 13, 2020

BUY
$76.57 - $98.0 $271,670 - $347,704
3,548 Added 12.73%
31,426 $2.87 Million
Q1 2020

May 14, 2020

BUY
$62.82 - $91.86 $207,117 - $302,862
3,297 Added 13.41%
27,878 $2.2 Million
Q4 2019

Feb 13, 2020

BUY
$78.51 - $87.4 $1.93 Million - $2.15 Million
24,581 New
24,581 $2.14 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $205B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Stewart Asset Management, LLC Portfolio

Follow Stewart Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stewart Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stewart Asset Management, LLC with notifications on news.